BriaCell Therapeutics Cor...
(BCTXW)
undefined
undefined%
At close: undefined
0.34
-0.03%
After-hours Dec 13, 2024, 04:03 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -4.93M | -20.30M | -26.84M | -428.33K | -3.69M | -4.40M | -4.15M | -2.58M | -1.70M | -2.68M | -8.15M | -368.69K | -995.72K | -1.08M | -900.74K | -228.81K | -98.93K | -116.41K | -8.58K |
| Depreciation & Amortization | 83.90K | 15.27K | 15.27K | 15.26K | 13.97K | 14.25K | 12.97K | 232.68 | 907.21 | 434.31 | 1.11K | 392.08 | 1.72K | 2.51K | 1.29K | 154.20 | - | - | - |
| Stock-Based Compensation | 1.80M | 2.19M | 3.07M | 1.97M | 1.69K | 46.08K | 365.49K | 218.25K | 496.21K | 396.86K | - | - | 27.73K | 443.38K | 15.92K | 76.74K | - | - | - |
| Other Working Capital | 1.74M | -4.19M | -640.46K | -876.44K | - | 787.90K | -346.51K | 833.17K | -46.41K | 61.05K | - | - | 16.07K | - | - | - | - | - | - |
| Other Non-Cash Items | -21.08M | -1.07M | -2.41K | 1.84M | 64.65K | -319.86K | 328.55K | - | 21.39K | 1.35M | 7.72M | -38.66K | -149.73K | 38.96K | 579.07K | -0.00 | -0.00 | 39.05K | - |
| Deferred Income Tax | - | -1.05M | 11.66M | -8.86M | 0.00 | 1.03 | 0.98 | - | - | -38.94K | - | - | 646.59K | - | 0.00 | - | - | - | - |
| Change in Working Capital | - | -3.53M | -391.29K | -2.28M | 2.45M | 787.90K | -358.51K | 830.37K | -22.03K | 41.45K | 59.29K | 38.44K | 87.92K | -96.80K | -4.92K | 11.32K | 11.52K | -10.40K | 8.58K |
| Operating Cash Flow | -24.13M | -23.74M | -12.48M | -7.75M | -1.16M | -3.87M | -3.81M | -1.54M | -1.20M | -935.26K | -363.97K | -368.52K | -381.49K | -690.76K | -309.37K | -140.59K | -87.41K | -87.76K | - |
| Capital Expenditures | -456.80K | - | - | - | - | - | - | - | - | -1.74K | -144.25K | -441.76K | -2.51M | -2.46M | -481.68K | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - | - | - | 531.08K | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | -453.63K | - | - | - | - | - | - | -1.11M | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - | - | - | - | 484.77K | 46.66K | - | - | - | - | - | - | - |
| Other Investing Acitivies | -225.00K | - | - | - | - | - | - | - | - | -845.56K | -83.39K | 269.66K | 607.58K | - | 52.77K | -155.54K | -24.78K | - | - |
| Investing Cash Flow | -681.80K | - | - | - | 0.00 | 1.02M | -453.63K | 120.35K | 158.78K | -316.21K | 257.14K | -125.43K | -1.90M | -3.56M | -428.91K | -155.54K | -24.78K | - | - |
| Debt Repayment | - | - | - | -330.40K | 22.47K | -95.68K | 516.58K | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | -47.29K | -10.17M | - | - | - | - | - | - | - | - | - | - | - | -115.11K | -106.59K | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | - | 1.59K | 6.43M | 13.70M | - | 113.96K | 219.52K | -119.89K | -174.21K | 33.55K | 1.60M | - | - | -589.81K | -115.11K | - | - | -49.03K | - |
| Financial Cash Flow | 4.42M | 3.95M | -3.74M | 65.00M | 1.08M | 2.28M | 4.06M | 2.32M | 801.90K | 1.59M | 1.60M | - | 24.95K | 6.73M | 1.31M | 724.02K | - | 439.28K | 88.40K |
| Net Cash Flow | -20.39M | -19.79M | -16.23M | 57.25M | -124.34K | -566.98K | -250.19K | 876.61K | -224.21K | 337.19K | 1.49M | -493.95K | -2.26M | 2.48M | 569.13K | 427.89K | -112.19K | 351.52K | 88.40K |
| Free Cash Flow | -24.58M | -23.74M | -12.48M | -7.75M | -1.16M | -3.87M | -3.81M | -1.54M | -1.20M | -937.00K | -508.21K | -810.28K | -2.89M | -3.15M | -791.05K | -140.59K | -87.41K | -87.76K | - |